Systematic review of patients’ and healthcare professionals’ views on patient‐initiated follow‐up in treated cancer patients

Janine Dretzke(University of Birmingham), David Moore(National Institute of Neurological Disorders and Stroke), Clare P Herd(University of Birmingham), Ava Lorenc(University of Bristol), Paul Nankivell(University of Birmingham), Ada Adriano(MSD (UK) Limited (United Kingdom)), Hisham Mehanna(University Hospitals Birmingham NHS Foundation Trust)
Cancer Medicine
June 16, 2023
10.1002/cam4.6243
Cited by 15

Related Papers

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
|Cochrane Database of Systematic Reviews|2020|1.3k
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
|The Lancet|2018|1k
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
|Cochrane Database of Systematic Reviews|2021|627
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC
|JAMA Oncology|2018|315
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
|The Lancet Oncology|2023|291